Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer

British Journal of Cancer

Volumn 95, Issue 7, 2006, Pages 811-816

  Kodama, H ^a   Nio, Y ^a   Iguchi, C ^a   Kan, N ^a  

^a Kodama Breast Clinic   (Japan)

Author keywords

Axillary dissection; Breast cancer; Level I dissection; Level III dissection; Randomised control study

Indexed keywords

FLUOROURACIL; TAMOXIFEN;

ARM EDEMA; ARTICLE; AXILLARY LYMPH NODE; BLEEDING; BREAST CANCER; CANCER SURGERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DISEASE FREE SURVIVAL; FEMALE; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MASTECTOMY; METASTASIS; OPERATION DURATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SURVIVAL RATE; TIME SERIES ANALYSIS;

ANTINEOPLASTIC AGENTS; AXILLA; BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; FLUOROURACIL; FOLLOW-UP STUDIES; HUMANS; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MASTECTOMY; MASTECTOMY, SEGMENTAL; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; TAMOXIFEN; TIME FACTORS;

EID: 33749351377     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/sj.bjc.6603364     Document Type: Article

References (29)

1. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C, Asselain B (1992) Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. The Breast Carcinoma Collaborative Group of the Institute Curie. Lancet 339: 1245-1248
2. Early Breast Cancer Trialists' Collaborative Group (1995) Effects of radiotherapy and surgery in early breast cancer. An overview of the randomized trials. N Engl J Med 333: 1444-1455
3. Early Breast Cancer Trialists' Collaborative Group (1998) Tamoxifen for early breast cancer: an overview of the randomized trials. Lancet 35: 1451-1467
4. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R (1983) Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557
5. Fisher B, Montague E, Redmond C, Barton B, Borland D, Fisher ER, Deutsch M, Schwarz G, Margolese R, Donegan W, Volk H, Konvolinka C, Gardner B, Cohn Jr I, Lesnick G, Cruz AB, Lawrence W, Nealon T, Butcher H, Lawton R (1977) Comparison of radical mastectomy with alternative treatments for primary breast cancer. A first report of results from a prospective randomized clinical trial. Cancer 39(6, Suppl): 2827-2839
6. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham DL, Deutsch M, Montague E, Margolese R, Foster R (1985) Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681
7. Lacour J, Bucalossi P, Cacers E, Jacobelli G, Koszarowski T, Le M, Rumeau-Rouquette C, Veronesi U (1976) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 37: 206-214
8. Lacour J, Le M, Caceres E, Koszarowski T, Veronesi U, Hill C (1983) Radical mastectomy versus radical mastectomy plus internal mammary dissection. Ten year results of an international cooperative trial in breast cancer. Cancer 51: 1941-1943
9. Lythgoe JP, Palmer MK (1982) Manchester regional breast study -5 and 10 year results. Br J Surg 69: 693-696
10. Meier P, Ferguson DJ, Karrison T (1989) A controlled trial of extended radical versus radical mastectomy. Ten-year results. Cancer 63: 188-195
11. NIH Consensus Conference (1991) Treatment of early-stage breast cancer. JAMA 265: 391-395
12. Noguchi M, Thomas M, Kitagawa H, Kinoshita K, Ohta N, Nagamori M, Miyazaki I (1993) Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases. Br J Cancer 67: 1368-1371
13. Noguchi S, Koyama H, Uchino J, Abe R, Miura S, Sugimachi K, Akazawa K, Abe O (2005) Postoperative adjuvant therapy with tamoxifen, tegafur plus uracil, or both in women with node-negative breast cancer: a pooled analysis of six randomized controlled trials. J Clin Oncol 23: 2172-2184
14. Ribeiro GG, Magee B, Swindell R, Harris M, Banerjee SS (1993) The Christie Hospital breast conservation trial: an update at 8 years from inception. Clin Oncol (R Coll Radiol) 5: 278-283
15. Rosen PP, Lesser ML, Kinne DW, Beattie EJ (1983) Discontinuous or 'skip' metastases in breast carcinoma. Analysis of 1228 axillary dissections. Ann Surg 197: 276-283
16. Sacre RA (1983) Clinical evaluation of axillar lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12: 169-173
17. Schoenfeld DA, Richter JR (1982) Nomograms for calculating the number of patients needed for a clinical trial with survival as an endpoint. Biometrics 38: 163-170
18. Shimane Breast Cancer Study Group (2006) Comparative effects of the administration period of adjuvant chemotherapy using doxifluridine (5′-DFUR) for 1 year versus 3 years after breast cancer surgery by the Shimane Breast Cancer Study group. Anticancer Res 26: 591-598
19. Smith III JA, Gamez-Araujo JJ, Gallager HS, White EC, McBride CM (1977) Carcinoma of the breast: analysis of total lymph node involvement versus level of metastasis. Cancer 39: 527-532
20. Stewart HJ, Prescott RJ, Forrest AP (2001) Scottish adjuvant tamoxifen trial: a randomized study updated to 15 years. J Natl Cancer Inst 93: 456-462
21. Tominaga T, Koyama H, Toge T, Miura S, Sugimachi K, Yamaguchi S, Hirata K, Monden Y, Nomura Y, Toi M, Kimijima I, Noguchi S, Sonoo H, Asaishi K, Ikeda T, Morimoto T, Ota J, Ohashi Y, Abe O (2003) Randomized controlled trial comparing oral doxifluridine plus oral cyclophosphamide with doxifluridine alone in women with node-positive breast cancer after primary surgery. J Clin Oncol 21: 991-998
22. Union Internationale Contre Cancer (1987) TNM Classification of Malignant Tumours, 4 edn. Berlin: Springer-Verlag
23. Union Internationale Contre Cancer (2002) TNM Classification of Malignant Tumours, 6 edn. Berlin: Springer-Verlag
24. Urban JA, Castro EB (1971) Selecting variations in extent of surgical procedure for breast cancer. Cancer 28: 1615-1623
25. Veronesi U, Cascinelli N, Greco M, Bufalino R, Morabito A, Galluzzo D, Conti R, De Lellis R, Delle Donne V, Piotti P (1985) Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes. Ann Surg 202: 702-707
26. Veronesi U, Marubini E, Mariani L, Valagussa P, Zucali R (1999) The dissection of internal mammary nodes does not improve the survival of breast cancer patients. 30-year results of a randomized trial. Eur J Cancer 35: 1320-1325
27. Veronesi U, Rilke F, Luini A, Sacchini V, Galimberti V, Campa T, Dei Bei E, Greco M, Magni A, Merson M (1987) Distribution of axillary node metastases by level of invasion. An analysis of 539 cases. Cancer 59: 682-687
28. Yang WT, Ahuja A, Tang A, Suen M, King W, Metreweli C (1996) High resolution sonographic detection of axillary lymph node metastases in breast cancer. J Ultrasound Med 16: 241-246
29. Zelen M (1979) A new design for randomized clinical trials. N Engl J Med 300: 1242-1245